Angiotensin II AT(1) receptor antagonists and platelet activation.
about
Platelet inhibition beyond conventional antiplatelet agents: expanding role of angiotensin receptor blockers, statins and selective serotonin reuptake inhibitorsEffects of blood pressure and the renin-angiotensin system on platelet activation in type 2 diabetes.Antiplatelet effect of catechol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 productionAngiotensin-converting enzyme inhibitors will help in improving stroke outcome if given immediately after strokeAntihypertensive medications for risk reduction of first and recurrent ischemic stroke.Interference with the renin-angiotensin system in heart failure.Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade.Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic miceTargeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.Cardioprotective effects of angiotensin II type 1 receptor blockade with olmesartan on reperfusion injury in a rat myocardial ischemia-reperfusion model.The impact of angiotensin II receptor blockade and the DASH diet on markers of endogenous fibrinolysis.Ecto-nucleotide pyrophosphatase/phosphodiesterase as part of a multiple system for nucleotide hydrolysis by platelets from rats: kinetic characterization and biochemical properties.Platelet activation in hypertension associated with hypercholesterolemia: effects of irbesartan.Angiotensin Converting Enzyme Inhibitor Has a Protective Effect on Decompression Sickness in Rats.
P2860
Q28200046-0DDAD539-8BB5-4AB3-9780-65C9FC617A48Q33609751-3B2D06C4-E36C-447C-A6AC-9D040F22E9B8Q34047510-E231ED42-539F-404E-8BA8-C63169B5D795Q34311942-BD282A54-7008-4873-B7C3-ABCEC16F5533Q35925696-A8873862-8328-4038-BE7B-C0ACB3ED613BQ36391915-312A884D-90F3-4EA9-AD21-AEDBD6DA9EA9Q36649671-92A5DF92-2C71-4E59-B7EF-1DBC429CCB85Q36857431-58B56063-97C9-4898-BBD6-8981DB0CBD60Q36863534-77801F84-76BE-4FA8-A8F0-95F10A173169Q43194532-9D9F7969-69E5-4B3A-AF77-191F95592EE2Q44010976-C377216B-B142-4C40-A5A5-E9EE40F0D6C1Q46899899-7E902B5E-44C4-426F-815A-E86E9ACA6B31Q51771267-17CB1750-4D96-46A6-8127-4FB12F883CBDQ54942300-6CE4C536-6B3E-4FB1-B87F-EB8160543E7C
P2860
Angiotensin II AT(1) receptor antagonists and platelet activation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Angiotensin II AT
@nl
Angiotensin II AT(1) receptor antagonists and platelet activation.
@ast
Angiotensin II AT(1) receptor antagonists and platelet activation.
@en
type
label
Angiotensin II AT
@nl
Angiotensin II AT(1) receptor antagonists and platelet activation.
@ast
Angiotensin II AT(1) receptor antagonists and platelet activation.
@en
prefLabel
Angiotensin II AT
@nl
Angiotensin II AT(1) receptor antagonists and platelet activation.
@ast
Angiotensin II AT(1) receptor antagonists and platelet activation.
@en
P2093
P356
P1476
Angiotensin II AT(1) receptor antagonists and platelet activation.
@en
P2093
A Lopez-Bloya
A López-Farré
L Sánchez de Miguel
P356
10.1093/NDT/16.SUPPL_1.45
P407
P478
16 Suppl 1
P577
2001-01-01T00:00:00Z